Bristol-Myers Squibb Co Joins Hands With Dutch UniQure On Gene Therapy For Cardiovascular Diseases

April 6, 2015 7:21 PM

67 0

Pharmaceutical giant Bristol-Myers Squibb Company (BMY), announced today its plans to join hands with a Dutch gene therapy company UniQure NV (NASDAQ:QURE) for enhancing efforts to develop potential gene therapies aimed at treating various cardiovascular diseases; the news sent UniQure's stock trading up by a hefty 52% to touch $34.42 in pre-market hours on Monday.

Bristol-Myers’ investment in the Holland-based biotech firm will offer it a significant advantage to enjoy access to UniQure’s proprietary gene therapy technology platform targeting congestive heart failure. In addition to gaining rights to UniQure's lead candidate and three other major potential th...

Read more

To category page